Artificial Int: Neurogenic Bowel Education in Spinal Cord Injury Patients
ArtInt
Artificial Intelligence Application of Neurogenic Bowel Training in Patients With Spinal Cord Injury
2 other identifiers
interventional
34
0 countries
N/A
Brief Summary
The aim of this study is to evaluate the effectiveness of patient education delivered through an artificial intelligence (AI)-based mobile application in the management of neurogenic bowel dysfunction in individuals with spinal cord injury. Within the scope of the study, it will be examined whether the mobile application reduces neurogenic bowel scores, contributes to maintaining stool scores within the normal range, and improves the quality of life of individuals. Accordingly, the AI-based education model to be developed is expected to facilitate the integration of bowel management practices into daily life, prevent complications, and enhance social participation. \-
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2025
CompletedFirst Posted
Study publicly available on registry
January 27, 2026
CompletedStudy Start
First participant enrolled
February 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
January 27, 2026
January 1, 2026
3 months
August 27, 2025
January 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Neurogenic Bowel Dysfunction (NBD) Score Assessed by the Neurogenic Bowel Dysfunction Scale
Neurogenic bowel dysfunction will be assessed using the Neurogenic Bowel Dysfunction (NBD) Scale, a validated questionnaire for individuals with spinal cord injury. The scale ranges from 0 to 47 points, with higher scores indicating more severe bowel dysfunction. The outcome measure is the change in total NBD score from baseline (Week 0) to Week 12.
Baseline (Week 0), Week 4, and Week 12
Change in Bowel Care Time Measured in Minutes
Bowel care time will be measured as the average time (in minutes) required to complete bowel care management. Time will be self-reported by participants. The outcome measure is the change in bowel care time from baseline (Week 0) to Week 12.
Baseline (Week 0), Week 4, and Week 12
Secondary Outcomes (1)
Change in Fecal Incontinence Rate
Baseline (Week 0), Week 4, and Week 12
Study Arms (2)
Control Group
NO INTERVENTIONThe control group consisted of participants who only received the hospital's routine NBD education. No additional intervention was provided. The NBD education was delivered by clinical nurses. At the end of the 4th and 12th weeks, the links for the post-tests were sent to the participants in the control group via WhatsApp messages to their phones. After the completion of the study, a link to the mobile application was also provided to the control group via WhatsApp along with an explanatory note.
intervention group
EXPERIMENTALİndividuals in the intervention group will receive the same routine education as the control group. In addition to the routine education, on the day of discharge, a link will be sent to their phones through which the mobile application will be downloaded. Participants will create an account in the mobile application by entering their name, surname, and password. The purpose of installing the mobile application on the day of discharge is to prevent individuals in the control group from becoming aware of the mobile application. After discharge, participants will be followed up during the 4th and 12th weeks.
Interventions
After discharge, the documents to be completed will be delivered to the intervention group participants via the mobile application and to the control group participants via WhatsApp. At the end of the study, after the final assessment is completed, participants will be informed of their group allocation, and those in the control group will be provided with access to the mobile application via a WhatsApp link.
Eligibility Criteria
You may qualify if:
- Volunteers who consent to participate.
- Age over 18 years.
- Diagnosed with spinal cord injury (SCI).
- Diagnosed with neurogenic bowel dysfunction (NBD).
- Not in spinal shock (return of the bulbocavernosus reflex).
- Having received routine NBD education at the study center within the last month.
You may not qualify if:
- Individuals with mental retardation.
- Individuals with visual and/or hearing impairments.
- Individuals with communication problems.
- Individuals with a history of additional injuries other than SCI (e.g., head trauma, pelvic injury, pelvic surgery).
- Individuals diagnosed with neurological disorders such as stroke, Parkinson's disease, polyneuropathy, or multiple sclerosis.
- Individuals with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD).
- Individuals diagnosed with gastrointestinal malignancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Senem Dumanlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
August 27, 2025
First Posted
January 27, 2026
Study Start
February 20, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
As the process cannot be anticipated, no plan has been established.